कृपया अन्य खोज का प्रयास करें
Haleon Pakistan Limited engages in the research and development, manufacture, marketing, and sale of consumer healthcare products primarily in Pakistan. The company offers products in the areas of pain relief under the Panadol brand; oral health under the Sensodyne and Parodontax brand names; respiratory health under the Panadol CF, Sancos, T-Day, Tandegyl, and Actified brands; nutrition and gastrointestinal health under the CaC-1000 PLUS, ENO, and QalSium-D brand names; and skin health under the Physiogel, Hydrozole, SunBlock 60, Lamisil, Acne Aid, Duofilm, SpectraBan, Brevoxyl, and Oilatum brands. It also exports its products. The company was incorporated in 2015 and is headquartered in Karachi, Pakistan. The company was formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited and changed its name to Haleon Pakistan Limited in January 2023. Haleon Pakistan Limited operates as a subsidiary of Glaxosmithkline Consumer Healthcare B.V.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Farhan Muhammad Haroon | - | 2021 | CEO & Executive Director |
Muhammad Zindah Moin Mohajir | - | 2018 | Independent Chairperson of the Board |
Sumru Atalay Besceli | - | 2022 | Non-Executive Director |
Dilawar Meghani | - | 2020 | Finance Director, CFO & Executive Director |
Syed Anwar Mahmood | - | 2016 | Independent Director |
Oussama Abbas | - | 2020 | Non-Executive Director |
Ayesha Aziz | - | 2021 | Non-Executive Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है